Literature DB >> 31362587

ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.

Zhiqiang Deng1,2,3, Junghyun Lim1,4, Qian Wang1, Kerry Purtell1, Shuai Wu5, Gloria M Palomo6, Haiyan Tan7, Giovanni Manfredi6, Yanxiang Zhao5, Junmin Peng7, Bo Hu8, Shi Chen2,3, Zhenyu Yue1.   

Abstract

Macroautophagy (autophagy) is a key catabolic pathway for the maintenance of proteostasis through constant digestion of selective cargoes. The selectivity of autophagy is mediated by autophagy receptors that recognize and recruit cargoes to autophagosomes. SQSTM1/p62 is a prototype autophagy receptor, which is commonly found in protein aggregates associated with major neurodegenerative diseases. While accumulation of SQSTM1 implicates a disturbance of selective autophagy pathway, the pathogenic mechanism that contributes to impaired autophagy degradation remains poorly characterized. Herein we show that amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD)-linked mutations of TBK1 and SQSTM1 disrupt selective autophagy and cause neurotoxicity. Our data demonstrates that proteotoxic stress activates serine/threonine kinase TBK1, which coordinates with autophagy kinase ULK1 to promote concerted phosphorylation of autophagy receptor SQSTM1 at the UBA domain and activation of selective autophagy. In contrast, ALS-FTLD-linked mutations of TBK1 or SQSTM1 reduce SQSTM1 phosphorylation and compromise ubiquitinated cargo binding and clearance. Moreover, disease mutation SQSTM1G427R abolishes phosphorylation of Ser351 and impairs KEAP1-SQSTM1 interaction, thus diminishing NFE2L2/Nrf2-targeted gene expression and increasing TARDBP/TDP-43 associated stress granule formation under oxidative stress. Furthermore, expression of SQSTM1G427R in neurons impairs dendrite morphology and KEAP1-NFE2L2 signaling. Therefore, our results reveal a mechanism whereby pathogenic SQSTM1 mutants inhibit selective autophagy and disrupt NFE2L2 anti-oxidative stress response underlying the neurotoxicity in ALS-FTLD.Abbreviations: ALS: amyotrophic lateral sclerosis; FTLD: frontotemporal lobar degeneration; G3BP1: GTPase-activating protein (SH3 domain) binding protein 1; GSTM1: glutathione S-transferase, mu 1; HMOX/HO-1: Heme oxygenase 1; IP: immunoprecipitation; KEAP1: kelch-like ECH associated protein 1; KI: kinase inactive; KIR: KEAP1 interaction region; KO: knockout; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MBP: maltose binding protein; NBR1: NBR1, autophagy cargo receptor; NFE2L2/Nrf2: nuclear factor, erythroid derived 2, like 2; NQO1: NAD(P)H quinone dehydrogenase 1; SQSTM1/p62: sequestosome 1; SOD1: superoxide dismutase 1, soluble; S.S.: serum starvation; TARDBP/TDP-43: TAR DNA binding protein; TBK1: TANK binding kinase 1; UBA: ubiquitin association; ULK1: unc-51 like autophagy activating kinase 1; WT: wild type.

Entities:  

Keywords:  ALS-FTLD; SQSTM1/p62; TBK1; phosphorylation; selective autophagy

Year:  2019        PMID: 31362587      PMCID: PMC7144840          DOI: 10.1080/15548627.2019.1644076

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  60 in total

1.  Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes.

Authors:  Ji-An Pan; Erica Ullman; Zhixun Dou; Wei-Xing Zong
Journal:  Mol Cell Biol       Date:  2011-05-31       Impact factor: 4.272

2.  Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD.

Authors:  Serena Lattante; Hortense de Calbiac; Isabelle Le Ber; Alexis Brice; Sorana Ciura; Edor Kabashi
Journal:  Hum Mol Genet       Date:  2014-11-19       Impact factor: 6.150

3.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

4.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

5.  Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.

Authors:  Jozsef Gal; Anna-Lena Ström; David M Kwinter; Renée Kilty; Jiayu Zhang; Ping Shi; Weisi Fu; Marie W Wooten; Haining Zhu
Journal:  J Neurochem       Date:  2009-09-18       Impact factor: 5.372

6.  Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.

Authors:  Kristopher Clark; Lorna Plater; Mark Peggie; Philip Cohen
Journal:  J Biol Chem       Date:  2009-03-22       Impact factor: 5.157

7.  Neuronal morphometry directly from bitmap images.

Authors:  Tiago A Ferreira; Arne V Blackman; Julia Oyrer; Sriram Jayabal; Andrew J Chung; Alanna J Watt; P Jesper Sjöström; Donald J van Meyel
Journal:  Nat Methods       Date:  2014-10       Impact factor: 28.547

8.  Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.

Authors:  Elizabeth Stewart; Justina McEvoy; Hong Wang; Xiang Chen; Victoria Honnell; Monica Ocarz; Brittney Gordon; Jason Dapper; Kaley Blankenship; Yanling Yang; Yuxin Li; Timothy I Shaw; Ji-Hoon Cho; Xusheng Wang; Beisi Xu; Pankaj Gupta; Yiping Fan; Yu Liu; Michael Rusch; Lyra Griffiths; Jongrye Jeon; Burgess B Freeman; Michael R Clay; Alberto Pappo; John Easton; Sheila Shurtleff; Anang Shelat; Xin Zhou; Kristy Boggs; Heather Mulder; Donald Yergeau; Armita Bahrami; Elaine R Mardis; Richard K Wilson; Jinghui Zhang; Junmin Peng; James R Downing; Michael A Dyer
Journal:  Cancer Cell       Date:  2018-08-23       Impact factor: 31.743

9.  ALS and Frontotemporal Dysfunction: A Review.

Authors:  Eugene Y Achi; Stacy A Rudnicki
Journal:  Neurol Res Int       Date:  2012-08-07

Review 10.  Protein aggregation in amyotrophic lateral sclerosis.

Authors:  Anna M Blokhuis; Ewout J N Groen; Max Koppers; Leonard H van den Berg; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2013-05-15       Impact factor: 17.088

View more
  43 in total

Review 1.  Autophagy in health and disease: From molecular mechanisms to therapeutic target.

Authors:  Guang Lu; Yu Wang; Yin Shi; Zhe Zhang; Canhua Huang; Weifeng He; Chuang Wang; Han-Ming Shen
Journal:  MedComm (2020)       Date:  2022-07-10

Review 2.  Autophagy in major human diseases.

Authors:  Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 3.  Approaches to Gene Modulation Therapy for ALS.

Authors:  Katharina E Meijboom; Robert H Brown
Journal:  Neurotherapeutics       Date:  2022-09-06       Impact factor: 6.088

Review 4.  Adipose-Derived Mesenchymal Stem Cells Combined With Extracellular Vesicles May Improve Amyotrophic Lateral Sclerosis.

Authors:  Xichen Wang; Yong Zhang; Tian Jin; Benson O A Botchway; Ruihua Fan; Lvxia Wang; Xuehong Liu
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

5.  SQSTM1-mediated clearance of cytoplasmic mutant TARDBP/TDP-43 in the monkey brain.

Authors:  Peng Yin; Dazhang Bai; Fuyu Deng; Chen Zhang; Qingqing Jia; Longhong Zhu; Laiqiang Chen; Bang Li; Xiangyu Guo; Jianmeng Ye; Zhiqiang Tan; Lu Wang; Shihua Li; Xiao-Jiang Li
Journal:  Autophagy       Date:  2021-12-22       Impact factor: 13.391

6.  The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability.

Authors:  Xinyue Wang; Ying Liu; Anna Han; Chunxiao Tang; Ran Xu; Linyuan Feng; Yang Yang; Liyan Chen; Zhenhua Lin
Journal:  Oncogene       Date:  2022-10-17       Impact factor: 8.756

7.  Selective autophagy of AKAP11 activates cAMP/PKA to fuel mitochondrial metabolism and tumor cell growth.

Authors:  Zhiqiang Deng; Xianting Li; Marian Blanca Ramirez; Kerry Purtell; Insup Choi; Jia-Hong Lu; Qin Yu; Zhenyu Yue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 8.  Multiple ways to a dead end: diverse mechanisms by which ALS mutant genes induce cell death.

Authors:  Yueh-Lin Tsai; James L Manley
Journal:  Cell Cycle       Date:  2021-03-15       Impact factor: 4.534

Review 9.  Selective Neuron Vulnerability in Common and Rare Diseases-Mitochondria in the Focus.

Authors:  Thomas Paß; Rudolf J Wiesner; David Pla-Martín
Journal:  Front Mol Biosci       Date:  2021-06-30

Review 10.  Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.

Authors:  Ramya Ranganathan; Shaila Haque; Kayesha Coley; Stephanie Shepheard; Johnathan Cooper-Knock; Janine Kirby
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.